A Study to Assess AFM13 in Patients With Hodgkin Lymphoma

Clinical trial NCT01221571 · COMPLETED

Trial details

NCT number: NCT01221571
Sponsor: Affimed GmbH
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Hodgkin Lymphoma

Start date: 2010-10-01
Primary completion: 2013-05-01
Enrollment: 28

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.